传统医学

Search documents
AI助力传统医学现代化 两岸共谋融合发展新路径
Bei Jing Shang Bao· 2025-09-22 06:36
9月19日至20日,由两岸科技创新中心、中关村人才协会、台湾人工智能产业协会共同主办的"两岸传统 医学科技化与AI技术整合对话会"在北京经济技术开发区成功举办。本次活动作为第28届京台科技论坛 的专场活动之一,以"传承、创新、融合、生态、永续发展"为主题,汇聚两岸百余位专家学者、企业代 表及行业协会负责人,共探传统医学与现代科技的深度融合之路。 据了解,京台科技论坛自1998年创办以来,已成为两岸经贸科技交流的重要品牌。本届论坛以"共育新 质生产力,携手融合新发展"为主题,进一步突出高新技术产业与生命健康等前沿领域的深度合作。本 次对话会的举办,不仅为两岸传统医学的科技化转型提供新思路,也为推动两岸产业融合与健康中国建 设注入新动能。 会议期间,多家机构签署合作项目协议,并发布共同倡议,启动"生命健康万里行"后续行动计划。两岸 科技创新中心作为推动京台产业融合的重要平台,已吸引89家合作企业和伙伴加入,累计接洽台资项目 近50项,未来将继续为两岸企业提供技术协同、孵化加速、市场对接等全方位服务。 本次对话会聚焦传统医学现代化核心痛点,旨在借助数智化和AI技术,解决传统医学在诊断标准化、 疗效验证等方面的瓶颈。 ...
增配医药!傅鹏博、高楠……明星基金经理二季度调仓曝光
券商中国· 2025-07-20 07:11
Core Viewpoint - The article highlights the ongoing strong performance of the innovative drug sector, with several fund managers increasing their allocations to this area, indicating a positive outlook for the future despite potential adjustments and volatility ahead [2][3][8]. Group 1: Fund Managers' Adjustments - Fund manager Fu Pengbo has increased allocations to the pharmaceutical sector, particularly in innovative drugs and traditional medicine benefiting from AI, while also adjusting positions in the export chain [4]. - Fund manager Gao Nan has shifted focus towards TMT (Technology, Media, and Telecommunications) and innovative drugs, with significant growth in fund size, indicating a strategic pivot in investment focus [5][6]. - Both fund managers express confidence in the continuation of the innovative drug market's upward trend, emphasizing the importance of evaluating company performance through upcoming mid-year reports [4][10]. Group 2: Market Dynamics and Trends - The innovative drug sector is seen as a necessary evolution rather than an option, with Chinese companies positioned to benefit from global competition and transparency in drug development [9][10]. - Factors contributing to the success of Chinese innovative drugs include high research efficiency, lower operational costs, and a well-established industry chain that supports rapid market entry and commercialization [9]. - The article notes that while the innovative drug sector has strong long-term potential, it has already experienced significant gains, suggesting that market corrections and fluctuations are likely in the near future [3][11].
文链东盟 智启未来
Guang Xi Ri Bao· 2025-05-31 02:11
Group 1: Cultural Showcase - The Guangxi exhibition at the 21st China (Shenzhen) International Cultural Industries Fair showcased a blend of traditional culture and modern technology, featuring unique cultural products and performances that highlight the region's ethnic diversity and artistic heritage [1][2][3] - Notable exhibits included traditional crafts, such as Zhuang brocade and Miao clothing, which attracted significant attention from both domestic and international visitors [2][3] - The exhibition emphasized the integration of non-material cultural heritage with contemporary design, creating a unique appeal that resonated with attendees [2] Group 2: Technological Integration - The exhibition featured advanced technology products, including AI electronic guitars and autonomous sightseeing vehicles, showcasing the potential for innovation in the cultural and tourism sectors [4] - The autonomous sightseeing vehicle was highlighted for its 360-degree perception and centimeter-level precision positioning, offering a new solution for scenic area transportation [4] - The integration of technology into cultural experiences was further demonstrated through interactive displays and digital content, enhancing visitor engagement [5] Group 3: Cultural Exchange and Collaboration - Guangxi played a pivotal role as a cultural connector between China and ASEAN, facilitating cultural exchange and cooperation through various initiatives and projects [5] - The exhibition included interactive experiences, such as AIGC-generated short films, which broke down language barriers and made cultural exchange more accessible and engaging [5] - During the fair, Guangxi secured significant partnerships, with eight enterprises signing agreements totaling 530 million yuan, covering areas such as industrial investment and technology development [6]